<SEC-DOCUMENT>0001437749-23-016266.txt : 20230531
<SEC-HEADER>0001437749-23-016266.hdr.sgml : 20230531
<ACCEPTANCE-DATETIME>20230531161552
ACCESSION NUMBER:		0001437749-23-016266
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230531
DATE AS OF CHANGE:		20230531

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NovaBay Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001389545
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				680454536
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-262550
		FILM NUMBER:		23981176

	BUSINESS ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		(510) 899-8800

	MAIL ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>nby20230531c_424b3.htm
<DESCRIPTION>FORM 424B3
<TEXT>
<html><head>
	<title>nby20230531c_424b3.htm</title>

	<!-- Generated by ThunderDome Portal - 5/31/2023 3:57:30 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Filed Pursuant to Rule 424(b)(3)</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Registration No. 333-262550</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Prospectus Supplement </b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>(To the Prospectus Dated</b>&nbsp;<b>February 10, 2022,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>As supplemented by the Prospectus Supplement Dated September 15, 2022)</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div style="text-align: center;"><img alt="pic1.jpg" src="pic1.jpg"></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>1,071,433 Shares of Common Stock </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Under that certain prospectus, dated February 10, 2022 (the &#8220;Prospectus&#8221;), filed as part of our registration statement on Form S-1 (File No. 333-262550), as initially supplemented by the Prospectus Supplement, dated September 15, 2022 (the &#8220;First Prospectus Supplement&#8221;), NovaBay Pharmaceuticals, Inc. (the &#8220;Company&#8221;) registered for resale, from time to time, by the selling stockholders named in the Prospectus (the &#8220;Selling Stockholders&#8221;) up to 1,071,433 shares (the &#8220;Warrant Shares&#8221;) of the Company&#8217;s common stock, par value $0.01 per share (the &#8220;Common Stock&#8221;), underlying the Common Stock purchase warrants (the &#8220;November 2021 Warrants&#8221;) issued by the Company as part of the units that were sold to each of the Selling Stockholders in a private placement that closed on November 2, 2021 (the &#8220;2021 Private Placement&#8221;). Subsequent to the closing of the 2021 Private Placement, as described in the First Prospectus Supplement and filings that the Company has made with the U.S. Securities and Exchange Commission that are incorporated into this second prospectus supplement (this &#8220;Second Prospectus Supplement&#8221;), the Company completed a warrant reprice transaction on September 9, 2022 (&#8220;2022 Warrant Reprice Transaction&#8221;). In connection with the 2022 Warrant Reprice Transaction, each Selling Stockholder entered into reprice letter agreements with the Company that provided for the November 2021 Warrants held by each Selling Stockholder to be amended (as so amended, the &#8220;Amended November 2021 Warrants&#8221;) to among other things (i) reduce the exercise price to $6.30 per share and (ii) extend the termination date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">This Second Prospectus Supplement modifies, supersedes and supplements certain information contained or incorporated by reference in the Prospectus, as supplemented by the First Prospectus Supplement. This Second Prospectus Supplement should be read in conjunction with the Prospectus and the First Prospectus Supplement, which are both to be delivered with this Second Prospectus Supplement. If there is any inconsistency between the information in the Prospectus, the First Prospectus Supplement and this Second Prospectus Supplement, you should rely on the information in this Second Prospectus Supplement. This Second Prospectus Supplement is not complete without, and may only be delivered or utilized in connection with, the Prospectus and First Prospectus Supplement, including any future amendments or supplements to it. You should read the entire Prospectus and any amendments or supplements carefully before you make an investment decision.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">On November 15, 2022, we effected a 1-for-35 reverse stock split of our outstanding Common Stock (the &#8220;Reverse Stock Split&#8221;). All share numbers and share price data included in this Second Prospectus Supplement have been adjusted to give effect to the Reverse Stock Split.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Common Stock is listed on the NYSE American under the symbol &#8220;NBY.&#8221; The last reported sale price of our Common Stock on May 30, 2023 was $0.65 per share.&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b>Investing in our Common Stock involves a high degree of risk. Before deciding whether to invest in our securities, you should consider carefully the risks that we have described under the caption </b>&#8220;<b>Risk Factors</b>&#8221;<b> on page 8 of the Prospectus and in the documents incorporated by reference into the Prospectus and in any amendments or supplements to it.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:18pt;"><b>Neither the U.S. Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this Supplement or the Prospectus. Any representation to the contrary is a criminal offense.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023 PRIVATE PLACEMENT AND WARRANT AMENDMENT AGREEMENTS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">As disclosed in the Company&#8217;s Current Report on Form 8-K, filed with the U.S. Securities and Exchange Commission on April 27, 2023 (the &#8220;Current Report&#8221;), we entered into a Securities Purchase Agreement (the &#8220;2023 Securities Purchase Agreement&#8221;) with certain existing accredited institutional investors (the &#8220;2023 Purchasers&#8221;) that provided for the issuance and sale in a private placement transaction (the &#8220;2023 Private Placement&#8221;) of (i) $3.3 million aggregate principal amount of Original Issue Discount Senior Secured Convertible Debentures Due November 1, 2024 (the &#8220;Debentures&#8221;), which may be converted or redeemed into up to an aggregate of 2,538,464 shares of Common Stock, (ii) new long-term Series B-1 warrants to purchase Common Stock, which are exercisable for up to an aggregate of 2,538,464 shares of Common Stock, and (iii) new short-term Series B-2 warrants to purchase Common Stock, which are exercisable for up to an aggregate of 2,538,464 shares of Common Stock. The closing of the 2023 Private Placement occurred on May 1, 2023. In connection with the closing of the 2023 Private Placement, Common Stock purchase warrants that the Company previously issued, which were owned by the 2023 Purchasers as well as certain other existing investors in prior Company private placements and warrant reprice transactions, were amended to lower the exercise price from $6.30 per share to $1.50 per share pursuant to Warrant Amendment Agreements (&#8220;Warrant Amendment Agreement&#8221;). The Selling Stockholders who were 2023 Purchasers in the 2023 Private Placement, Alpha Capital Anstalt, Altium Growth Fund, LP, Bigger Capital Fund, LP and District 2 Capital Fund LP, each entered into a Warrant Amendment Agreement that provided for its respective Common Stock purchase warrants to be amended, including the Amended November 2021 Warrants that each owned. The Amended November 2021 Warrants held by the other Selling Stockholders named in the Prospectus who did not participate in the 2023 Private Placement will continue to have an exercise price of $6.30 per share.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Since not all of the Amended November 2021 Warrants were amended, references in the Prospectus, as amended by this Second Prospectus Supplement, to the exercise price shall be $1.50 per share for only the Amended November 2021 Warrants held by the four Selling Stockholders listed above who were 2023 Purchasers, and references to the exercise price shall be $6.30 per share for all other Amended November 2021 Warrants held by the other Selling Stockholders named in the Prospectus, who were not 2023 Purchasers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">This Second Prospectus Supplement is being filed to update the information in the Prospectus and the First Prospectus Supplement with the information summarized above and contained in the Current Report as well as other documents incorporated into the Prospectus.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">The date of this prospectus supplement is May 31, 2023.</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>pic1.jpg
<TEXT>
begin 644 pic1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !C <@# 2(  A$! Q$!_\0
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MW6E30P0V,DAC65I7VCYATZU\_AL//$58T:2NWHCWJM6-*#G-V2/H03[A]_\
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M^B>.)8B&71=!^]IL><_$GXB)\/=+N=4G4WVK:M<DH@&^:]DD;H>Y)8U^CO\
MP2<_X-X+[X_:=9_$[]IFRO+:SNV6YT7P6)2A:'&X/==P#P0GIUJA_P &Z_\
MP3=LOVFOBUK/Q]^(^B"^T7P[.MIX+MKR,/ ]PO+W.P\-M(P,\9S7[K1Z?(&W
M[LDJ!M)X'X_TK#BKBBM.L\)1TBM-/(OA/AFA1PT,377-4:N<W\,/A1X>^"_A
M2V\/>$]!TOP[HEG&([>ST^W6WB50,?PCD^YKII,HN[D =6ZM27LK6T0(^?M@
M\8KA/CI^T+X?_9^^'ESX@\2W@M;1'$$$29,M[._"0QCJSL<8 K\]]^K4]G"[
MDS[FK4C37-+8[::6.649R,\Y'?%-D'F@^N,*V./Q%?EE^U[\;_\ @H)XYGO/
M%O@&Q\*?"7P!IMH9H;.[BAU+4[U<Y#R!\A?EQD#ISFOFC]CS_@XQ^./P+^/<
M.A_M&?V3XF\#7<_DW6N:;IPMKK1VQ@$(G#)GKD<5]'2X4S&IA_K%)J26]M6>
M5_;N%E5]BVD^Q^[>IZ';:Y8R6]W;P7EO+P\,\8D208P>&R*_.C_@IW_P;?\
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M-/M-U!;B4X7S9 N[MQFHG\5:<%.W4+'@=#<)G^=?@S_P<)?'6[^._P"WW;>
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MO;9+H,/WZ^8&'3GK7LG_  3T^+Z?LS_M^?#;Q8[1QV&IW?\ 8VH22N0BI/\
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M9&_9_M;<XJY\6_A5XJ_9]^+&M^"/%]I%9Z_HKH\ODG,;QL,AE/3%4-/U,)=
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M,VV5SGY66JGBI,Z%9_\ 7];G.?\ IJM26N#N_NOP,U6\8 OIMHN>!>VX&/\
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M)_#B4G'X5\$?\''<2S_\%'?"<I(17\'KAB?^FS<8_&OP#A/_ )*^M3:UO/\
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M;L#7@%E=6^J;7M+A)%EPX[!0?KUKJ? 'Q%\5?!?QMI'BCPEK+:+KVDL3!=Q
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MZEJ]]+&1;W%U%RD*GH6WX)[5_2A"<JPZG<2WL3VKR_\ 9#_9*\&_L:? [0O
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M("_:[R4$JFX@#@=R:^YR_P 1^(J/^RQGJNZU/E\=P;DV(?M:E--]S\;?!/\
MP;S?M'^)]=BM_$_BKP+X8TX@[[VRD>ZF'H%3 K[,_8 _X(+?#;]CJ[MO$OB*
M]O\ XE>/H6>1-5U$!;:V+@C$<1XZ>N:^J]-_:T\ >(/V:O\ A<-GXCM;CX=Q
MZ>VKKK"<H;9,[W Z]01BK_[-G[1/@O\ :R^$FF>._ 6J)K/AC60YM;H1[1(4
M;:V0>>M<^=\<\1XR@XUYN,(NS:5E?MZG3EW"N58*_L::U/S_ /'G_!L%\.O'
MGQ(US7C\2_'6FQZY=R7GV&W5/)MG=BQ"$\[<FLS7/^#6#X?:CI<]L_Q9^(,4
M<B; 2(CM;^][U^I.H:LNG6,L[.L4$,32R,>B!022?08!KR?]DK]M?X;?MN^&
M=2U_X<^)K'Q':Z'J4FDW;P$@P3KU4@]FZJW0BO/AQ7GCI-TJTG'9F[X>R]S4
MI4U<Z_\ 9X^$'_"A?@QX7\&KJ][K:>&+".P2^N@!-=*@P&8#C./2NYF7(R3G
MC&*P_'_CO3OAGX'U7Q#K5RMGI6B6TEU>3L/]5&@R6_*OBW4_^#B3]F.33;B7
M3/&-[JT\$3,D$&GRYG8=%#8QR:\?#X#&8V3J4H.7=^;.S%X[#X./[Z22/BC_
M (./OBI<>+/VY_ O@V&Z@6R\,: U](H;GSII,?-[[5_6OBBSE,5^",*&0JOH
M377?M5_'J?\ ;3_:T\3?%"6R;2(-<=(;*SE&9+6&)0HWGL6Z^Q)KD_$MJP\.
M3P6ZO)?W96WMT0?-N<[?E^AK^L>%L)_9F24E5T:6I_+W%V,AF6<VI:IGZ/\
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M^_9J^*WBJVMYM!T/Q3\1]5ETSPRR[4\.I&P5H=O\+$\D=L5Z9_P<$V/]J_\
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MCI[T442^!#?Q%=U"C  QZ8J6#E3TYZ\=:**YZ>US5_"1W'$H&!C'3%/@C5%
M"@ = !116\=_D9H?L SP/RJ(PH%^ZOY445A+^+%#6XJCMVQTH7Y7XXSUXHHJ
4X*T]!5=B;=1NHHKJ)#-%%% '_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
